A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

7.6K views

DOI:

10.3791/62952

September 30th, 2021

In This Article

Summary

The refined tail vein transection (TVT) bleeding model in anesthetized mice is a sensitive in vivo method for the assessment of hemophilic bleeding. This optimized TVT bleeding model uses blood loss and bleeding time as endpoints, refining other models and avoiding death as an endpoint.

Abstract

Tail bleeding models are important tools in hemophilia research, specifically for the assessment of procoagulant effects. The tail vein transection (TVT) survival model has been preferred in many settings due to sensitivity to clinically relevant doses of FVIII, whereas other established models, such as the tail clip model, require higher levels of procoagulant compounds. To avoid using survival as an endpoint, we developed a TVT model establishing blood loss and bleeding time as endpoints and full anesthesia during the entire experiment. Briefly, anesthetized mice are positioned with the tail submerged in temperate saline (37°C) and dosed with the test compound in the right lateral tail vein. After 5 min, the left lateral tail vein is transected using a template guide, the tail is returned to the saline, and all bleeding episodes are monitored and recorded for 40 min while collecting the blood. If no bleeding occurs at 10 min, 20 min, or 30 min post-injury, the clot is challenged gently by wiping the cut twice with a wet gauze swab. After 40 min, blood loss is quantified by the amount of hemoglobin bled into the saline. This fast and relatively simple procedure results in consistent and reproducible bleeds. Compared to the TVT survival model, it uses a more humane procedure without compromising sensitivity to pharmacological intervention. Furthermore, it is possible to use both genders, reducing the total number of animals that need to be bred, in adherence with the principles of 3R's. A potential limitation in bleeding models is the stochastic nature of hemostasis, which can reduce the reproducibility of the model. To counter this, manual clot disruption ensures that the clot is challenged during monitoring, preventing primary (platelet) hemostasis from stopping bleeding. This addition to the catalog of bleeding injury models provides an option to characterize procoagulant effects in a standardized and humane manner.

Introduction

Animal models are essential for understanding the pathogenesis of hemophilia and developing and testing treatment regimens and therapies. The Factor VIII knock-out mouse (F8-KO) is a widely used model for the study of hemophilia A1,2. These mice recapitulate key features of the disease and have been widely used for development of treatments, such as recombinant FVIII products3,4,5 and gene therapy strategies6,7.

There are various bl....

Access restricted. Please log in or start a trial to view this content.

Protocol

All procedures described in this protocol have been approved by the Animal Welfare Body at Novo Nordisk A/S, and the Danish Animal Experiments Inspectorate, The Danish Ministry of Food, Agriculture, and Fisheries. The optimized 40 minutes method includes anesthesia and dosing time in the design (Figure 1). Hemophilic mice of both genders between 10-16 weeks of age are required for this procedure.

1. Preparations before the study

  1. Prepare the dosing solutions in the correct concentrations.
  2. Start the water bath and heat to 37 °C. Fill the 15 mL centrifuge tubes for blood collection with ....

Access restricted. Please log in or start a trial to view this content.

Results

To assess the applicability of the optimized model, a study was performed in F8-KO (C57BL genetic background) mice administered with a commercially available recombinant factor VIII replacement therapy (rFVIII); four different doses were tested: 1 IU/kg, 5 IU/kg, 10 IU/kg, and 20 IU/kg. Furthermore, we tested the corresponding vehicle (negative) control in F8-KO mice and wild-type (WT) group using C57BL mice as a positive control group to assess the response range in the model.

Following the o.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This optimized method of tail vein transection (TVT) has several advantages compared to the TVT survival method. The animals are fully anesthetized for the entire study duration, which makes mouse handling easier and increases animal wellbeing. Further, unlike the TVT survival model, overnight observation is not required, and this optimized model offers the possibility of measuring blood loss and observing the exact bleeding time over 40 min. Also, longer periods of bleeding in conscious animals can cause death by exsang.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors are or were employees and/or shareholders of Novo Nordisk A/S at the time this research was carried out.

Acknowledgements

Esther Bloem and Thomas Nygaard are acknowledged for support with measurements of FVIII in plasma. Bo Alsted is acknowledged for drawing and machining the template and cutting blocks.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
#11 Scalpel bladeSwann-Morton503
15 mL centrifuge tubesGreiner Bio-One, Austria188271
30 G needles connected to 300 µL precision (insulin) syringes for dosingBD Micro-Fine + U-100 insulin syringe320830
AdvateTakeda, JapanRecombinant factor VIII replacement therapy (rFVIII)
Alcohol pads 70% ethanolHartmann, Soft-Zellin999 979
CentrifugeOmnifuge 2.0 RS, Heraus Sepatech
Cutting template (Stainless steel)Self produced, you are welcomed to contact the authors for the exact drawingsSupplementary Figure 2: Size specifications: 20 mm x 40 mm x 10 mm (L x B x H). Groove: 3 mm depth and 3 mm width; radius 1.5 mm
Erythrocytes (RBC) lysing solutionLysebio, ABX Diagnostics906012
Gauze
Haematological analyserSysmexCT-2000iv
Heating lamp on standPhillipsIR250
Heating pad with thermostatCMAmodel 150
Hemoglobin standards and controls - 8.81 mmol / l batch dependentHemoCue, DenmarkHemoCue calibrator, 707037Standards and controls are made from 2 different glasses of HemoCue calibrator. The value is determined against the International Reference Method for Hemoglobin (ICSH).
Isofluorane anaesthesia system complete with tubes, masks and induction boxSigma Delta Dameca
IsofluraneBaxter26675-46-7
Magnifier with lightsEschenbach
Measuring template (Aluminum)Self produced, you are welcomed to contact the authors for the exact drawingsSupplementary Figure 1: Size specifications: 20 mm x 40 mm x 10 mm (L x B x H). Groove: 2.5 mm depth and 2.5 mm width; radius 1.25 mm
Micropipettes + tipsFinnpipette
PhotometerMolecular Devices Corporation, CA, USASpectraMax 340 photometer
Prism SoftwareGraphPad, San Diego, CA, USAVersion 9.0.1
Saline 0.9% NaClFresenius Kabi, Sweden883264
Special tail marker block for TVT tail cut
Tail holder
Vacuum liquid suctionVacusafe comfort, IBS
Waterbath and thermostatTYP 3/8 Julabo

References

  1. Bi, L., et al. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nature Genetics. 10 (1), 119-121 (1995).
  2. Bi, L., et al. Further characterization of factor VIII-deficient mice cr....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Tail Bleeding ModelBlood Loss MeasurementBleeding TimeProcoagulant EffectsRecombinant Factor VIIIAnesthetized MiceClot DisruptionHemoglobin Analysis